Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

When Is Arthroplasty Recommended? New ACR/AAHKS Guideline Offers Considerations for Timing of Elective Hip or Knee Arthroplasty

Ruth Jessen Hickman, MD  |  Issue: December 2023  |  November 1, 2023

“It’s frustrating for both the patient and physician to delay surgery, but we didn’t really know whether the data showed if the delay made a difference,” says Dr. Hannon. “So one purpose of the guideline was to determine the effectiveness of delaying surgery for additional nonoperative treatments in patients who elected to proceed with surgery using shared decision making with their physician.”

Guideline writers also wanted to explore the value of potentially delaying surgery to modify risk factors for poor outcomes, such as high BMI, poor glycemic control in diabetes and nicotine use.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The current guideline recommendations apply specifically to patients with radiographically verified moderate to severe osteoarthritis of the hip or knee or, less commonly, with advanced symptomatic osteonecrosis (e.g., secondary to inflammatory arthritis). These patients have moderate to severe pain or loss of function and have previously attempted a form of nonoperative treatment.1

Dr. Goodman

Dr. Goodman adds, “All these patients have tried at least one modality [such as physical therapy, NSAIDs or intraarticular injections] and have either failed to benefit or have lost benefit from these other nonsurgical interventions.” Clinicians have assessed these patients’ comorbidities and prior nonoperative treatments, and they are indicated for total joint arthroplasty.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thus, this guideline on surgical timing complements existing the 2019 ACR guideline on osteoarthritis that focuses on management strategies for osteoarthritis of the hand, knee or hip of varying severity, which may include such modalities as weight loss, physical therapy and NSAID use.2

After a systematic literature review and a rating of evidence quality, a Voting Panel discussed the evidence for PICO questions (i.e., population, intervention, comparator, outcomes questions) and voted for or against specific recommendations. The panel achieved high consensus for most of the recommendations, all of which members categorized as conditional, partly due to the relatively low quality of evidence available for this specific population. For the additional context and extended discussion of the full recommendations, see the full guideline.

“This guideline should serve as a starting point for discussions between patients and physicians, so that the patient can participate in a shared decision-making process,” says Dr. Goodman.

Third-party payers often dictate whether patients are approved for arthroplasty, even when patients with severe disease have tried multiple nonoperative therapies without an acceptable improvement in pain, function & quality of life.

Delaying for Additional Interventions

Conditional recommendations: Proceed to arthroplasty instead of delaying arthroplasty three months. Proceed to arthroplasty over delaying arthroplasty for a trial of physical therapy, braces or ambulatory aids, NSAIDs, intra-articular glucocorticoid injections or viscosupplementation injections.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Clinical Criteria/GuidelinesConditionsGuidanceOsteoarthritis and Bone Disorders Tagged with:arthroplastyrecommendations

Related Articles

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    Right: The same view as 2A, with the common peroneal nerve outlined in yellow with a cross-sectional area of 21 mm2.

    Case Report: Ultrasound Reveals Cause of Post-Arthroplasty Knee Pain

    April 15, 2020

    A 65-year-old woman was referred by an orthopedist to a rheumatologist for left knee pain. Previously, in 2014, she underwent left total knee arthroplasty (TKA) for severe osteoarthritis in a different institution. Following the procedure, she experienced severe chronic anterolateral knee pain at rest, exacerbated by walking. Because she was rendered wheelchair bound and required…

    Flare Risk Increases When Medication Is Stopped Prior to Arthroplasty

    June 21, 2018

    After total hip or knee arthroplasty, flares are common in patients with rheumatoid arthritis (RA), according to a recently published study.1 Higher disease activity at baseline appears to be linked to flares, but use of such medications as biologics and methotrexate did not independently predict flaring. “Contrary to the notion that patients with established RA…

    Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement

    December 1, 2014

    Resurfacing procedure preserves bone, lasts longer, allows patients higher level of functionality

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences